On [**1-14**], she received a an aranesp shot in [**State 108**] - her HCT was 28.6.
In the ED, initial vs were: T 98.1 P 82 BP 127/54 R 16 O2 sat 100.
- [**10/2092**]: Diagnosed during evaluation of mildly abnormal LFTs.
- [**2099**]:  The patient completed 40 weeks on bevacizumab plus erlotinib (on protocol), which she discontinued in [**4-/2100**] secondary to disease progression.
The fracture site was biopsied and showed no metastatic disease.
- [**2102-4-19**] CT scan:  Stable hepatic lesions with a mild decrease in size of the previously noted portacaval lymph node.
-[**2104-10-7**] C1D1 Everolimus on 08-034 A Study Evaluating FDG-PET as a Predictive Marker For mTOR Directed Therapy with RAD001 in Metastatic Renal Cell Cancer  Social History: Significant for an infrequent alcohol use (about 3 drinks per week).
Physical Exam: -- per admitting resident -- Vitals: T: afebrile BP: 124/44 P: 80 R: 13 O2:  100 on RA General: Alert, oriented, no acute distress HEENT: NCAT, Sclera anicteric, MMM, oropharynx clear.
No ulcers Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, occ.
wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen:  soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema  Pertinent Results: [**2105-2-21**] 04:25PM   WBC-7.9 RBC-3.85* HGB-9.2* HCT-28.8* MCV-75* MCH-24.0* MCHC-32.0 RDW-16.9* [**2105-2-21**] 04:25PM   NEUTS-88.3* LYMPHS-8.7* MONOS-1.6* EOS-1.0 BASOS-0.3 [**2105-2-21**] 04:25PM   GLUCOSE-120* UREA N-14 CREAT-1.2* SODIUM-140 POTASSIUM-4.4 CHLORIDE-101 TOTAL CO2-26 ANION GAP-17 [**2105-2-21**] 04:25PM   ALT(SGPT)-37 AST(SGOT)-50* ALK PHOS-186* TOT BILI-0.3 [**2105-2-21**] 04:25PM   ALBUMIN-3.5 CALCIUM-9.3 PHOSPHATE-2.8 MAGNESIUM-2.0 [**2105-2-21**] 04:25PM   LIPASE-37 [**2105-2-21**] 04:25PM   PT-12.0 PTT-25.7 INR(PT)-1.0 [**2105-2-21**] 04:25PM   PLT COUNT-261  Brief Hospital Course: # tongue swelling - Likely [**12-23**] angioedema.
Her medications include an ACEI, which can cause angioedema.
She was discharged on a short prednisone taper, and her ACEI was switched to amlodipine for blood pressure control.
The patient could also benefit from Allergy follow-up as an outpatient for further workup of her tongue swelling.
Medications on Admission: ENALAPRIL MALEATE - 20 mg once a day EVEROLIMUS [AFINITOR] - 10 mg Tablet - daily FLUOXETINE [PROZAC] - 20 mg Capsule daily LEVOTHYROXINE - 150 mcg Tablet - 1once a day ONDANSETRON HCL [ZOFRAN] - 4 mg Tablet - [**11-22**] Q6hr NAUSEA OPIUM TINCTURE - 10 mg/mL Tincture - 0.3-1 ml by mouth every 2-6 hours as needed for diarrhea to maximum of 6 ml in 24 hours OXYBUTYNIN CHLORIDE - 5 mg Tab by mouth once a day PROCHLORPERAZINE [COMPAZINE] - 10 mg Tablet q6 NAUSEA ZOLPIDEM - 10 mg Tablet qHS ACETAMINOPHEN 500 mg Tablet q6 prn ASPIRIN -   81 mg Tablet BISACODYL [DULCOLAX] -  (OTC) - Dosage uncertain HYDROCORTISONE -  (OTC) - 0.5 % Cream -  facial rash LOPERAMIDE [IMODIUM A-D] -  (OTC) - 2 mg Tablet -  Discharge Medications: 1.
Opium Tincture 10 mg/mL Tincture Sig: 0.3-1 ml PO q2-6h as needed for diarrhea: max 6 ml / 24 hrs.
You were observed in the intensive care unit and your symptoms improved with antihistamines and steroids, after which you were discharged.
Followup Instructions: You have the following appointments schedule: Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 5387**], MD Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2105-2-23**] 1:30 Provider: [**First Name11 (Name Pattern1) **] [**Initials (NamePattern4) **] [**Last Name (NamePattern4) 30162**], RN Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2105-2-23**] 1:30 Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 12633**], MD Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2105-2-23**] 1:30 .
We would recommend scheduling an outpatient appointment with an allergist for further evaluation, but you can discuss this decision with Dr. [**Last Name (STitle) **].
[**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] [**Name8 (MD) **] MD [**MD Number(1) 292**]  Completed by:[**2105-2-22**
